Mountain air or heart risk? trial asks if high altitude is safe for aortic stenosis patients.

NCT ID NCT06894550

First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time

Summary

This trial investigates whether a short stay at high altitude (up to 3,545 meters) is safe for people with asymptomatic moderate or severe aortic stenosis. Participants will undergo heart tests—including ECG, echocardiography, and exercise stress tests—both at low altitude and after ascending. The goal is to measure changes in exercise capacity, heart function, and rhythm to see if altitude poses a risk.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
short-term high-altitude exposure (ascending to 3545 m above sea level)
What this could lead to
If safe, it could provide evidence to update guidelines, allowing people with aortic stenosis to enjoy high-altitude travel without unnecessary restrictions.
What could go wrong
This is a small, early-stage observational study with only 41 participants. It measures surrogate markers, not hard outcomes like heart attacks or death, so results may not be definitive.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALTITUDE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University Hospital Inselspital, Bern

    Bern, Canton of Bern, CH-3010, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.